Targeted
Focal Therapy (TFT) is a new
approach for management of early
stage, organ-confined prostate
cancer. It involves selective
destruction of only the areas of cancer within
the prostate and sparing the
rest of the healthy prostatic
tissue and surroundings. This
selective destruction can be
achieved through freezing or
heating (microwaves, laser,
etc.) the tumor. The
rationale behind this approach
is to preserve quality of life
by minimizing the side effects
often caused during prostate
cancer surgery, which inevitable damages vital structures around the
prostate such as the bladder,
urinary sphincter, and nerves in
the vicinity of the prostate and
the rectum.
3D
Mapping is the 3-dimensional,
real-life reconstruction of the
prostate gland based on
pathology results from prostatic
biopsies integrated
to ultrasound and CT-scan
imaging of the gland in a
transperineal plane. With the
use of innovative software, the
rendering of a 3D image
of the prostate, including the
malignant lesions, allows us to identify exactly
where the cancer is located; subsequently we can treat
only the cancer using TFT.
See an example of the different
steps from Patient Admission to
Follow-up: [
Patient algorithm ]
|